4.4 Review

The past, present and future of anti-malarial medicines

Journal

MALARIA JOURNAL
Volume 18, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12936-019-2724-z

Keywords

Malaria; Plasmodium; Mechanism of action; Drug discovery; Drug development

Funding

  1. Australian Research Council
  2. Medicines for Malaria Venture [LP150101226]
  3. Australian Research Council [LP150101226] Funding Source: Australian Research Council

Ask authors/readers for more resources

Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact. Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine. A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated. Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available